BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 32661826)

  • 1. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme.
    Zhao H; Zhou X; Yuan G; Hou Z; Sun H; Zhai N; Huang B; Li X
    Clin Transl Oncol; 2021 Mar; 23(3):565-571. PubMed ID: 32661826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
    Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
    J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A robust two-gene signature for glioblastoma survival prediction.
    Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
    J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cancer/testis antigens is correlated with improved survival in glioblastoma.
    Freitas M; Malheiros S; Stávale JN; Biassi TP; Zamunér FT; de Souza Begnami M; Soares FA; Vettore AL
    Oncotarget; 2013 Apr; 4(4):636-46. PubMed ID: 23592437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma.
    Cheng ZX; Song YX; Wang ZY; Wang Y; Dong Y
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4079-4086. PubMed ID: 29028093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
    Han J; Puri RK
    J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-cimp status prediction of glioblastoma samples using mRNA expression data.
    Baysan M; Bozdag S; Cam MC; Kotliarova S; Ahn S; Walling J; Killian JK; Stevenson H; Meltzer P; Fine HA
    PLoS One; 2012; 7(11):e47839. PubMed ID: 23139755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma.
    Prasad B; Tian Y; Li X
    Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
    Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic significance of TCTN1 in human glioblastoma.
    Meng D; Chen Y; Zhao Y; Wang J; Yun D; Yang S; Chen J; Chen H; Lu D
    J Transl Med; 2014 Oct; 12():288. PubMed ID: 25304031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme.
    Wang K; Lu Y; Liu Z; Diao M; Yang L
    Biomed Res Int; 2022; 2022():7858477. PubMed ID: 35155681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
    Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
    Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
    Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K
    Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma.
    Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H
    Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAMSN1 is highly expressed and associated with a poor survival in glioblastoma multiforme.
    Yan Y; Zhang L; Xu T; Zhou J; Qin R; Chen C; Zou Y; Fu D; Hu G; Chen J; Lu Y
    PLoS One; 2013; 8(11):e81905. PubMed ID: 24278465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis.
    Xu P; Yang J; Liu J; Yang X; Liao J; Yuan F; Xu Y; Liu B; Chen Q
    BMC Med Genomics; 2018 Nov; 11(1):96. PubMed ID: 30382873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel methylation signature predicts radiotherapy sensitivity in glioma.
    Feng Y; Li G; Shi Z; Yan X; Wang Z; Jiang H; Chen Y; Li R; Zhai Y; Chang Y; Zhang W; Yuan F
    Sci Rep; 2020 Nov; 10(1):20406. PubMed ID: 33230136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional polymorphism in the pre‑miR‑146a gene influences the prognosis of glioblastoma multiforme by interfering with the balance between Notch1 and Notch2.
    Liu R; Li W; Wu C
    Mol Med Rep; 2015 Oct; 12(4):5475-81. PubMed ID: 26165719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated mRNA and microRNA expression signature for glioblastoma multiforme prognosis.
    Xiong J; Bing Z; Su Y; Deng D; Peng X
    PLoS One; 2014; 9(5):e98419. PubMed ID: 24871302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.